chemical factory

China CJC-1295 Manufacturer | High Purity CJC-1295 Lyophilized Powder

As a China-based manufacturer and supplier, I present CJC-1295 items designed for research and development. Our portfolio includes CJC-1295, CJC-1295 Peptide, CAS 863288-34-0, CJC-1295 Research Peptide, and we offer High Purity CJC-1295 in CJC-1295 Lyophilized Powder form. Buyers can rely on stable quality, precise dosing, and consistent lot-to-lot purity. We are a dedicated CJC-1295 Supplier and CJC-1295 Manufacturer, focusing on science-driven support for labs, CROs, and pharmaceutical R&D. Our lyophilized powder ensures longer shelf life and easy reconstitution for experiments. We provide competitive pricing, fast lead times, and compliant documentation for importers and distributors. If you operate in China or abroad, our team can tailor packaging and certificates to your regulatory needs. I invite you to contact us for verified COA, HPLC data, and bulk discounts on high purity materials.

Hot Selling Product

CJC-1295, CJC-1295 Peptide ,CAS 863288-34-0 ,CJC-1295 Research Peptide, CJC-1295 Supplier, CJC-1295 Manufacturer, High Purity CJC-1295 ,CJC-1295 Lyophilized Powder Application Guarantees Peak Performance

High-purity CJC-1295 (CAS 863288-34-0) is supplied as lyophilized powder tailored for research use. Each batch of CJC-1295 peptide comes with full analytical documentation (HPLC, MS, amino acid analysis) and a Certificate of Analysis demonstrating >98% purity, lot-to-lot consistency and stability. The lyophilized format eases handling and accurate reconstitution for assay development, peptide research, and preclinical studies, ensuring application performance you can trust. As a reliable supplier and manufacturer, we offer scalable GMP-aligned production, stringent QC procedures, custom packaging, flexible MOQs and temperature-controlled global logistics. Fast lead times, technical support and comprehensive compliance documentation streamline procurement and guarantee peak performance in your projects.

{ CJC-1295, CJC-1295 Peptide ,CAS 863288-34-0 ,CJC-1295 Research Peptide, CJC-1295 Supplier, CJC-1295 Manufacturer, High Purity CJC-1295 ,CJC-1295 Lyophilized Powder Application Guarantees Peak Performance}
Attribute Information
Molecule Type Peptide; Growth Hormone Releasing Hormone (GHRH) analog with Drug Affinity Complex (DAC)
CAS Number 863288-34-0
Synonyms CJC-1295; CJC-1295 DAC; DAC-CJC-1295
Form Lyophilized powder
Mechanism of Action Binds to GHRH receptors to stimulate growth hormone (GH) release; DAC prolongs in vivo half-life by binding to serum albumin, enabling extended activity
Typical Applications Biomedical research on the growth hormone axis; pharmacology studies; not approved for clinical use
Storage Lyophilized at recommended temperatures; reconstituted solutions stored at 2–8°C and used promptly
Purity Research-grade; commonly described as high-purity for scientific use
Safety and Handling Handle with standard laboratory peptide practices; use appropriate PPE; dispose of waste per guidelines
Regulatory Status Not approved for human or veterinary use; intended for research purposes only

Related Products

Logistics and Transportation

CJC-1295, CJC-1295 Peptide ,CAS 863288-34-0 ,CJC-1295 Research Peptide, CJC-1295 Supplier, CJC-1295 Manufacturer, High Purity CJC-1295 ,CJC-1295 Lyophilized Powder For the Current Year Trusted by Pros

Data Dimension: Batch Purity Progression (Hypothetical Dataset)

1 2 3 4 5 6 7 8 9 10 11 12 100 90 80 70 60 50 40 30 20 10 0
Note: This is a hypothetical dataset illustrating purity progression across production batches for a peptide reference material. Purity is a measure often obtained by analytical techniques such as HPLC, representing the percentage of the target peptide relative to impurities. The x-axis shows batch numbers, and the y-axis shows purity percentage. Such charts help quality control teams observe stability, detect deviations, and guide process optimization.

This explanation accompanies the provided chart, offering an in-depth interpretation of the observed trends in batch purity for a hypothetical research peptide. The line graph summarizes twelve sequential production batches, illustrating a relatively high overall purity with values clustering around mid-to-high 90s. The initial batches show a slight variance as the process is scaled and the purification workflow is validated. A minor dip around batch four could reflect adjustments to reaction conditions, chromatographic parameters, or variations in starting materials; such fluctuations are common when establishing a robust purification protocol. The subsequent rise and stabilization of purity around 98–99% in later batches suggest successful optimization, tighter control of critical process parameters, and improved reproducibility across runs. While purity is a critical quality attribute, it is not the sole determinant of material quality. Impurities, including closely related isoforms or solvent residues, can influence downstream biological assays. Therefore, a comprehensive quality control strategy should incorporate multi-dimensional analytics, such as impurity profiling, residual solvent testing, mass balance checks, and particle analysis, to provide a complete assessment of material integrity. This chart demonstrates how a simple univariate line chart can convey meaningful trend information that supports decision-making in release planning, process improvement initiatives, and ongoing quality assurance for peptide-based research materials. In practical settings, manufacturers often integrate such trend data with additional dimensions to create a holistic dashboard enabling proactive intervention and continuous process optimization.

Top Selling Products